---
figid: PMC5050298__emm201679f6
figtitle: Schematic model representing MSP as a negative regulator of NASH in hepatocytes
  and macrophages
organisms:
- NA
pmcid: PMC5050298
filename: emm201679f6.jpg
figlink: /pmc/articles/PMC5050298/figure/fig6/
number: F6
caption: Schematic model representing MSP as a negative regulator of NASH in hepatocytes
  and macrophages. Mediators of inflammatory stress—FFA, LPS or oxLDL—induce gene
  expression of key pro-inflammatory (Tnfα, Il-6 and Mcp-1) and lipogenic (Srebf-1
  and Fas) markers in hepatocytes and macrophages, precipitating a pathophysiological
  condition termed NASH. MSP, a hepatokine and ligand for the RON receptor tyrosine
  kinase, activates AMPK signaling pathway, in turn stimulating fatty acid oxidation
  (via the upregulation of Pgc-1α, Cpt-1 and Aco) and inhibiting inflammation and
  lipogenesis in ex vivo and in vitro models mimicking NASH. AMPK, AMP-activated protein
  kinase; Aco, acyl-CoA oxidase; Cpt-1, carnitine palmitoyltransferase I; FFA, free
  fatty acid; IL-6, interleukin 6; LPS, lipopolysaccharide; Mcp-1, monocyte chemoattractant
  protein-1; MSP, macrophage-stimulating protein; oxLDL, oxidized low-density lipoprotein;
  Pgc-1α, peroxisome proliferator-activated receptor-γ (PPARγ) coactivator-1α RON,
  recepteur d'origine nantais; TNFα, tumor necrosis factor-α.
papertitle: MSP is a negative regulator of inflammation and lipogenesis in ex vivo
  models of non-alcoholic steatohepatitis.
reftext: Dipanjan Chanda, et al. Exp Mol Med. 2016 Sep;48(9):e258.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9398804
figid_alias: PMC5050298__F6
figtype: Figure
organisms_ner:
- Danio rerio
redirect_from: /figures/PMC5050298__F6
ndex: bd895bb1-deaf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5050298__emm201679f6.html
  '@type': Dataset
  description: Schematic model representing MSP as a negative regulator of NASH in
    hepatocytes and macrophages. Mediators of inflammatory stress—FFA, LPS or oxLDL—induce
    gene expression of key pro-inflammatory (Tnfα, Il-6 and Mcp-1) and lipogenic (Srebf-1
    and Fas) markers in hepatocytes and macrophages, precipitating a pathophysiological
    condition termed NASH. MSP, a hepatokine and ligand for the RON receptor tyrosine
    kinase, activates AMPK signaling pathway, in turn stimulating fatty acid oxidation
    (via the upregulation of Pgc-1α, Cpt-1 and Aco) and inhibiting inflammation and
    lipogenesis in ex vivo and in vitro models mimicking NASH. AMPK, AMP-activated
    protein kinase; Aco, acyl-CoA oxidase; Cpt-1, carnitine palmitoyltransferase I;
    FFA, free fatty acid; IL-6, interleukin 6; LPS, lipopolysaccharide; Mcp-1, monocyte
    chemoattractant protein-1; MSP, macrophage-stimulating protein; oxLDL, oxidized
    low-density lipoprotein; Pgc-1α, peroxisome proliferator-activated receptor-γ
    (PPARγ) coactivator-1α RON, recepteur d'origine nantais; TNFα, tumor necrosis
    factor-α.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - kctd12.2
  - tnfa
  - tnfb
  - il6
  - fas
  - srebf1
  - ppargc1a
---
